disease & medicine, microbiology, immunology

Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.

A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.

Stanford University researchers determined the code from spare drops in discarded vials of the COVID-19 vaccine and published it on GitHub.

Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

Instead, the full report will be available in mid-March.

The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.

A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.

A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.

Around 100 people were infected at a scientific meeting hosted by Biogen in Boston in February. Then they went back home, taking the virus with them.

So far, there are three patients known to have been infected with SARS-CoV-2 twice, and in at least one case the second time around was asymptomatic.

Following a string of outbreaks, the University of North Carolina at Chapel Hill will move to an online-only semester.

The Johns Hopkins University researcher bucked the prevailing idea that the body would not launch an immune response against its own tissues, and in doing so established an entirely new scientific discipline.

None of the breastfed infants in the study tested positive for SARS-CoV-2 within the first two weeks of life.

By revealing that animals could develop immune responses against their own tissues, the physician-scientist established an entirely new field of science.

Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.

Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.